FDA Drug Application (022545) for TEKAMLO by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number022545
Product Number001
FormTABLET;ORAL
DosageEQ 150MG BASE;EQ 5MG BASE
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTEKAMLO
Active IngredientALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE



Back to FDA Applications sponsored by NOVARTIS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.